LEADER 01517nam  2200409Ia 450 
001 9910699567003321
005 20230902161550.0
035   $a(CKB)5470000002403255
035   $a(OCoLC)707467015
035   $a(EXLCZ)995470000002403255
100   $a20110316d2010      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEntry threats and pricing in the generic drug industry$b[electronic resource] /$fBrett Wendling, Steven Tenn
210  1$aWashington, DC :$cBureau of Economics, Federal Trade Commission,$d[2010]
215   $a1 online resource (27 pages) $cdigital, PDF file
225 1 $aWorking paper ;$vno. 301
300   $aTitle from title screen (viewed Mar. 9, 2011).
300   $a"June 2010."
320   $aIncludes bibliographical references (pages 18-20).
410  0$aWorking paper (United States. Federal Trade Commission. Bureau of Economics) ;$vno. 301.
606   $aGeneric drugs$xPrices$zUnited States
606   $aPharmaceutical industry$zUnited States
615  0$aGeneric drugs$xPrices
615  0$aPharmaceutical industry
700   $aWendling$b Brett$01386015
701   $aTenn$b Steven$01386013
712 02$aUnited States.$bFederal Trade Commission.$bBureau of Economics.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699567003321
996   $aEntry threats and pricing in the generic drug industry$93471504
997   $aUNINA